Beijing Tiantan Biological Products Co., Ltd. (SHA:600161)

SHA:600161 Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	-	2,686	4,555	3,713	4,330	1,748
Cash & Short-Term Investments	2,686	2,686	4,555	3,713	4,330	1,748
Cash Growth	-43.45%	-41.04%	22.68%	-14.25%	147.68%	23.69%
Accounts Receivable	-	1,121	94.13	1,173	1,027	695.59
Other Receivables	-	13.45	39.08	28.36	22.27	16.93
Receivables	-	1,134	133.21	1,201	1,050	712.52
Inventory	-	3,869	2,844	2,332	2,144	2,172
Other Current Assets	-	33.4	36.53	24.87	22.27	23.64
Total Current Assets	-	7,722	7,569	7,271	7,546	4,656
Property, Plant & Equipment	-	5,848	4,886	4,055	2,631	1,997
Long-Term Investments	-	143.2	146.06	146.06	146.06	121.59
Goodwill	-	572.15	173.92	173.92	127.93	115.01
Other Intangible Assets	-	917.05	686.88	441.63	370.99	252.44
Long-Term Deferred Tax Assets	-	41.77	46.74	60.63	67.01	63.11
Long-Term Deferred Charges	-	507.82	470.26	552.69	362.46	174.08
Other Long-Term Assets	-	117.66	208.66	228.88	326.85	161.34
Total Assets	-	15,870	14,188	12,929	11,578	7,541
Accounts Payable	-	81.45	179.1	69.39	73.7	45.86
Accrued Expenses	-	170.46	168.69	163.21	150.02	146.85
Short-Term Debt	-	-	-	-	-	200.13
Current Portion of Long-Term Debt	-	-	-	112.99	108.15	126.25
Current Portion of Leases	-	8.96	17.95	10.82	16.51	-
Current Income Taxes Payable	-	148.21	61.85	73.79	44.86	36.63
Current Unearned Revenue	-	213.19	357.26	292.72	215.31	200.66
Other Current Liabilities	-	498.07	494.78	434.44	201.03	182.98
Total Current Liabilities	-	1,120	1,280	1,157	809.58	939.36
Long-Term Debt	-	-	-	253.75	366.25	474.59
Long-Term Leases	-	44.86	24.42	25.62	18.01	-
Long-Term Unearned Revenue	-	107.44	99.56	101.9	92.69	80.83
Long-Term Deferred Tax Liabilities	-	62.44	28.85	30.87	20.14	11.15
Other Long-Term Liabilities	-	1.24	1.24	4.1	4.1	4.1
Total Liabilities	-	1,336	1,434	1,574	1,311	1,510
Common Stock	-	1,977	1,648	1,648	1,373	1,254
Additional Paid-In Capital	-	2,463	2,793	2,793	3,067	274.62
Retained Earnings	-	6,698	5,382	4,355	3,612	2,989
Comprehensive Income & Other	-	-0.1	-0.1	-0.1	-0.1	-0.1
Total Common Equity	11,139	11,139	9,823	8,795	8,052	4,518
Minority Interest	-	3,394	2,932	2,560	2,215	1,513
Shareholders' Equity	14,533	14,533	12,754	11,356	10,267	6,031
Total Liabilities & Equity	-	15,870	14,188	12,929	11,578	7,541
Total Debt	53.82	53.82	42.37	403.17	508.92	800.97
Net Cash (Debt)	2,632	2,632	4,513	3,310	3,821	947.15
Net Cash Growth	-44.08%	-41.68%	36.34%	-13.38%	303.40%	-6.48%
Net Cash Per Share	1.32	1.33	2.28	1.66	1.97	0.52
Filing Date Shares Outstanding	1,977	1,977	1,977	1,977	1,977	1,806
Total Common Shares Outstanding	1,977	1,977	1,977	1,977	1,977	1,806
Working Capital	-	6,602	6,290	6,113	6,736	3,717
Book Value Per Share	5.63	5.63	4.97	4.45	4.07	2.50
Tangible Book Value	9,650	9,650	8,962	8,180	7,553	4,150
Tangible Book Value Per Share	4.88	4.88	4.53	4.14	3.82	2.30
Buildings	-	2,711	2,241	1,957	963.02	949.32
Machinery	-	2,760	2,218	1,996	1,258	1,177
Construction In Progress	-	2,478	2,044	1,532	1,623	1,030

Updated Oct 25, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.